STOCK TITAN
  1. Home
  2. DMAQR

Deep Medicine Stock Price, News & Analysis

DMAQR NASDAQ

Company Description

Deep Medicine (NASDAQ: DMAQR) is a publicly traded company.

DMAQR stock has gained 150.0% over the past year.

This page provides a comprehensive overview of DMAQR stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
+150%
Performance 1 year
$0.0
Market Cap
0.0
Shares outstanding

Deep Medicine (DMAQR) stock. Over the past 12 months, the stock has gained 150.0%.

Latest News

View All
—

TRUGOLF, INC. AND DEEP MEDICINE ACQUISITION CORP. CLOSE BUSINESS COMBINATION; TRUGOLF BECOMES PUBLICLY TRADED COMPANY

acquisition
-3.33%

TRUGOLF, INC. AND NASDAQ-LISTED SPAC DEEP MEDICINE ACQUISITION CORP. ANNOUNCE FORM S-4 REGISTRATION STATEMENT DECLARED EFFECTIVE BY THE U.S. SECURITIES AND EXCHANGE COMMISSION AND MAILING OF DEFINITIVE PROXY STATEMENT

acquisition
-2.44%

Deep Medicine Acquisition Corp. Announces its Filing of Registration Statement on Form S-4 in Connection with Merger with TruGolf, Inc.

acquisition
+13.71%

Deep Medicine Acquisition Corp. and TruGolf, Inc. Announce the Execution of a Definitive Merger Agreement

acquisition
-8.70%

Deep Medicine Acquisition Corp. Announces Listing Transfer to the Nasdaq Capital Market 

acquisition

Deep Medicine has 5 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 3 with negative movement. Key topics include acquisition. View all DMAQR news →

SEC Filings

View All

No SEC filings available for DMAQR.

Financial Highlights

View Full Financials
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months